SALIX PHARMACEUTICALS LTD
10-Q, EX-27.1, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: SALIX PHARMACEUTICALS LTD, 10-Q, EX-10.28, 2000-11-14
Next: METROPOLITAN HEALTH NETWORKS INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           7,011
<SECURITIES>                                         0
<RECEIVABLES>                                      256
<ALLOWANCES>                                         0
<INVENTORY>                                      2,108
<CURRENT-ASSETS>                                 9,856
<PP&E>                                             630
<DEPRECIATION>                                     442
<TOTAL-ASSETS>                                  10,206
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        28,009
<OTHER-SE>                                    (23,809)
<TOTAL-LIABILITY-AND-EQUITY>                    10,206
<SALES>                                            852
<TOTAL-REVENUES>                                14,589
<CGS>                                              819
<TOTAL-COSTS>                                      819
<OTHER-EXPENSES>                                12,272
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  1,611
<INCOME-TAX>                                         9
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,602
<EPS-BASIC>                                       0.15
<EPS-DILUTED>                                     0.14


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission